Merck To Work With AmoyDx On Colorectal Cancer Liquid Biopsy Assay
Germany-based Merck will work to develop the test based on AmoyDx's real-time polymerase chain reaction technology, with goals to launch in China in 2017.
Germany-based Merck will work to develop the test based on AmoyDx's real-time polymerase chain reaction technology, with goals to launch in China in 2017.